Taisho Pharmaceutical (Japan)
In research, Taisho Pharmaceutical (Japan) stands highest in Chemistry (#2,403 of 2,902 worldwide), Neuroscience (#1,868 of 2,157 worldwide) and Biochemistry, Genetics and Molecular Biology (#5,222 of 5,801 worldwide), over all time.
- World rank, all time
- #32,755 of 34,923
- Rank in Japan
- #1,623 of 1,923
- Research works
- 1.1k ▼ 30% vs 2018-21
- Citations
- 27k 24.9 per fractional work
- Top-10% rate
- 12.9% all institutions 10.0%
- vs its own fields
- 0.73× 1.00× is exactly expected
- Open access
- 41% world 40%
- International
- 6% world 18%
What is Taisho Pharmaceutical (Japan) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| ChemistryField | #2,403 of 2,902 | 8.0% | 131 | |
| NeuroscienceField | #1,868 of 2,157 | 5.2% | 130 | |
| Biochemistry, Genetics and Molecular BiologyField | #5,222 of 5,801 | 5.4% | 286 | |
| Life SciencesDomain | #9,949 of 11,023 | 5.5% | 517 | |
| Molecular BiologySubfield | #3,451 of 3,729 | 4.7% | 186 | |
| MedicineField | #13,822 of 14,558 | 7.4% | 331 | |
| Health SciencesDomain | #15,987 of 16,688 | 7.1% | 353 | |
| Physical SciencesDomain | #17,314 of 17,446 | 7.0% | 188 |
Each strip is that field's whole ranked pool, with the notch where Taisho Pharmaceutical (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Taisho Pharmaceutical (Japan) work in?
In 2022-now, 58% of research at Taisho Pharmaceutical (Japan) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (57%), Biochemistry, Genetics and Molecular Biology (21%), Neuroscience (5%). It does 2.1× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 14 fields, with their numbers
- Health Sciences2557.5%
- Medicine2556.9%
- Nursing00.5%
- Health Professions00.2%
- Life Sciences1432.5%
- Physical Sciences36.4%
- Chemistry12.7%
- Engineering12.0%
- Environmental Science01.1%
- Materials Science00.3%
- Mathematics00.3%
- Social Sciences23.5%
- Psychology23.5%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.7×. Every wedge is a field page.
All 14 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics6.67×1 works
- Biochemistry, Genetics and Molecular Biology3.86×9 works
- Immunology and Microbiology3.79×2 works
- Neuroscience3.08×2 works
- Medicine2.96×25 works
- Chemistry1.74×1 works
- Psychology1.16×2 works
- Nursing1.04×0 works
- Environmental Science0.23×0 works
- Mathematics0.22×0 works
- Agricultural and Biological Sciences0.16×0 works
- Engineering0.13×1 works
- Materials Science0.08×0 works
- Health Professions0.07×0 works
- Pharmacology, Toxicology and Pharmaceutics 6.7×
- Biochemistry, Genetics and Molecular Biology 3.9×
- Immunology and Microbiology 3.8×
- Neuroscience 3.1×
- Medicine 3.0×
- Chemistry 1.7×
- Psychology 1.2×
- Nursing 1.0×
- Environmental Science 0.2×
- Mathematics 0.2×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.1×
- Materials Science 0.1×
- Health Professions 0.1×
Who are the top researchers at Taisho Pharmaceutical (Japan)?
Ranked on the quality score, Kenichi Fukumoto, Mari Aoki and Yukihiro Chino lead among researchers whose main affiliation is Taisho Pharmaceutical (Japan).
- 1
Kenichi Fukumoto
Japan · #840,689 worldwide 1.5k citations · 26 works
- 2
Mari Aoki
Japan · #1,664,620 worldwide 1.9k citations · 81 works
- 3
Yukihiro Chino
Japan · #3,709,295 worldwide 917 citations · 24 works
- 4
Michihiko Iijima
Japan · #3,758,691 worldwide 2.4k citations · 33 works
- 5
Mitsuo Murata
Japan · #3,816,183 worldwide 2k citations · 45 works
- 6
Takemasa Kojima
Japan · #3,822,501 worldwide 806 citations · 21 works
- 7
Masaharu Tamai
Japan · #3,926,835 worldwide 1.2k citations · 21 works
- 8
Noriyuki Miyata
Japan · #3,938,838 worldwide 3.2k citations · 73 works
- 9
Yuji Takaoka
Japan · #3,973,130 worldwide 1.2k citations · 38 works
- 10
Kazunori Hanada
Japan · #4,209,197 worldwide 3.9k citations · 83 works
Which keywords describe research at Taisho Pharmaceutical (Japan)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Angiogenesis, Metabolism, Autoantibodies, Cancer Therapy, Resistance Training, Cell Signaling and Reactive Oxygen Species.
- Therapeutic Targets
- Monoclonal Antibodies
- Exercise
- Transcriptional Regulation
- Pulmonary Involvement
- Circadian Rhythms
- Tissue Inhibitors of Metalloproteinases
- Performance Analysis
- Fibroblast Activation Protein
- Cytochrome P450
- Toll-like Receptors
- Extracellular Matrix
- Muscle-Derived Interleukin-6
- Exercise-Induced Oxidative Stress
- Immune Function
- Cancer Progression
- Resistance Training
- Epidemiology
- Autoantibodies
- Angiogenesis
- Inflammation
- Metabolism
- Cancer Therapy
- Cell Signaling
- Reactive Oxygen Species
- Tumor Microenvironment
- Cytokines
- Fibrosis
- Oxidative Stress
- Matrix Metalloproteinases
- Metabolic Syndrome
- Extracellular Matrix Remodeling
- Immunosuppression
- Synaptic Plasticity
- Training Load
- Hypertension
- Systemic Sclerosis
- Cardiovascular Function
- Rheumatoid Arthritis
- Nutrition
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation6▲ 6.6×20 topics
- Angiogenesis4▲ 28×5 topics
- Metabolism3▲ 14×8 topics
- Autoantibodies3▲ 29×3 topics
- Cancer Therapy3▲ 11×6 topics
- Epidemiology3▲ 1.57×11 topics
- Cell Signaling2▲ 35×4 topics
- Resistance Training2▲ 60×2 topics
- Reactive Oxygen Species2▲ 12×3 topics
- Cancer Progression2▲ 26×2 topics
- Tumor Microenvironment2▲ 10×3 topics
- Immune Function2▲ 56×2 topics
- Cytokines2▲ 14×4 topics
- Exercise-Induced Oxidative Stress2▲ 137×1 topic
- Fibrosis2▲ 21×3 topics
- Muscle-Derived Interleukin-62▲ 137×1 topic
- Oxidative Stress2▲ 2.5×8 topics
- Extracellular Matrix2▲ 22×2 topics
- Matrix Metalloproteinases2▲ 28×3 topics
- Toll-like Receptors2▲ 35×3 topics
- Metabolic Syndrome2▲ 4.6×5 topics
- Cytochrome P4502▲ 105×2 topics
- Extracellular Matrix Remodeling2▲ 223×1 topic
- Fibroblast Activation Protein2▲ 81×1 topic
- Immunosuppression2▲ 38×1 topic
- Performance Analysis2▲ 17×1 topic
- Synaptic Plasticity2▲ 16×3 topics
- Tissue Inhibitors of Metalloproteinases2▲ 223×1 topic
- Training Load2▲ 53×1 topic
- Circadian Rhythms1▲ 28×2 topics
- Hypertension1▲ 11×3 topics
- Pulmonary Involvement1▲ 73×1 topic
- Systemic Sclerosis1▲ 73×1 topic
- Transcriptional Regulation1▲ 17×3 topics
- Cardiovascular Function1▲ 68×2 topics
- Exercise1▲ 21×2 topics
- Rheumatoid Arthritis1▲ 26×2 topics
- Monoclonal Antibodies1▲ 26×2 topics
- Nutrition1▲ 5.3×2 topics
- Therapeutic Targets1▲ 15×3 topics
Which research topics does Taisho Pharmaceutical (Japan) publish most on?
By volume in 2022-now: Exercise and Physiological Responses, Sports Performance and Training, Peptidase Inhibition and Analysis and Protease and Inhibitor Mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Exercise and Physiological Responses Rehabilitation 2 works
- 2 Sports Performance and Training Orthopedics and Sports Medicine 2 works
- 3 Peptidase Inhibition and Analysis Oncology 2 works
- 4 Protease and Inhibitor Mechanisms Cancer Research 2 works
- 5 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
- 6 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 7 Muscle metabolism and nutrition Cell Biology 1 works
- 8 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
- 9 Eicosanoids and Hypertension Pharmacology Biochemistry 1 works
- 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Taisho Pharmaceutical (Japan)'s research output changed?
Output in 2022-2025 was 30% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Taisho Pharmaceutical (Japan) as a percentage of every work published that year, 0.00014% in 2024.
Fractional works of Taisho Pharmaceutical (Japan) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.7% in 1997.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Taisho Pharmaceutical (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
